RSLS 外匯新聞
ReShape And Vyome To Merge In All-stock Deal; ReShape To Substantially All Of Its Assets To Biorad
Metabolic health-solutions company ReShape Lifesciences (RSLS) and Vyome Therapeutics, Inc., announced Tuesday that they have entered into a definitive merger agreement under which ReShape and Vyome will combine in an all-stock transaction.
RTTNews
|
114天前
